Phase 1/2 trial of temsirolimus and sorafenib in the...

  • Main
  • 2018 / 01
  • Phase 1/2 trial of temsirolimus and sorafenib in the...

Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572

Schiff, David, Jaeckle, Kurt A., Anderson, S. Keith, Galanis, Evanthia, Giannini, Caterina, Buckner, Jan C., Stella, Phillip, Flynn, Patrick J., Erickson, Bradley J., Schwerkoske, John F., Kaluza, Ves
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.31219
Date:
January, 2018
File:
PDF, 289 KB
english, 2018
Conversion to is in progress
Conversion to is failed